MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 165 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $31,443,000 | +127.0% | 599,151 | +43.9% | 0.03% | +158.3% |
Q2 2020 | $13,849,000 | +792.9% | 416,251 | +630.1% | 0.01% | +500.0% |
Q1 2020 | $1,551,000 | -89.7% | 57,014 | -92.5% | 0.00% | -83.3% |
Q4 2019 | $15,090,000 | -10.3% | 764,848 | -41.1% | 0.01% | -14.3% |
Q3 2019 | $16,815,000 | -16.5% | 1,297,486 | -19.8% | 0.01% | -22.2% |
Q2 2019 | $20,135,000 | -19.0% | 1,617,290 | -5.5% | 0.02% | -21.7% |
Q1 2019 | $24,862,000 | +51.8% | 1,711,090 | +15.3% | 0.02% | +27.8% |
Q4 2018 | $16,379,000 | -51.5% | 1,483,590 | +15.6% | 0.02% | -48.6% |
Q3 2018 | $33,748,000 | -37.5% | 1,283,200 | -54.2% | 0.04% | +20.7% |
Q2 2018 | $54,025,000 | +109.1% | 2,801,900 | +96.8% | 0.03% | +3.6% |
Q1 2018 | $25,835,000 | +17.0% | 1,423,400 | -10.1% | 0.03% | +16.7% |
Q4 2017 | $22,083,000 | -17.6% | 1,583,000 | +9.3% | 0.02% | -25.0% |
Q3 2017 | $26,797,000 | +98.8% | 1,448,500 | +81.7% | 0.03% | +88.2% |
Q2 2017 | $13,476,000 | +262.6% | 797,400 | +186.4% | 0.02% | +240.0% |
Q1 2017 | $3,717,000 | -37.8% | 278,400 | -29.9% | 0.01% | -44.4% |
Q4 2016 | $5,976,000 | +74.6% | 397,100 | +35.6% | 0.01% | +50.0% |
Q3 2016 | $3,423,000 | -13.1% | 292,800 | -19.7% | 0.01% | -14.3% |
Q2 2016 | $3,938,000 | -58.6% | 364,670 | -64.6% | 0.01% | -61.1% |
Q1 2016 | $9,508,000 | +16.4% | 1,029,051 | +86.9% | 0.02% | 0.0% |
Q4 2015 | $8,171,000 | +13.6% | 550,586 | +25.6% | 0.02% | +5.9% |
Q3 2015 | $7,194,000 | -32.4% | 438,366 | -6.1% | 0.02% | -29.2% |
Q2 2015 | $10,649,000 | +198.8% | 466,851 | +99.1% | 0.02% | +200.0% |
Q1 2015 | $3,564,000 | +28.5% | 234,451 | +1.8% | 0.01% | +14.3% |
Q4 2014 | $2,773,000 | -33.2% | 230,351 | -37.1% | 0.01% | -36.4% |
Q3 2014 | $4,154,000 | -36.3% | 366,351 | -32.2% | 0.01% | -26.7% |
Q2 2014 | $6,526,000 | +31.8% | 540,251 | +27.1% | 0.02% | +25.0% |
Q1 2014 | $4,953,000 | +450.3% | 425,134 | +611.5% | 0.01% | +500.0% |
Q2 2013 | $900,000 | – | 59,751 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |